NCT01674205View on ClinicalTrials.gov

Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Influenza, Human
Interventions
BIOLOGICAL

A/swine/Missouri/4296424/2006 (H2N3) x A/Ann Arbor/6/60 ca (H2N3 MO 2006/AA ca)

BIOLOGICAL

A/chicken/Hong Kong/G9/97 (H9N2) x A/Ann Arbor/6/60 ca (H9N2 G9/AA ca)

BIOLOGICAL

2012-2013 trivalent seasonal live attenuated influenza vaccine (FluMist®)

BIOLOGICAL

Vaccine placebo (Leibovitz-15 [L-15])

BIOLOGICAL

Vaccine placebo (FluMist®)

Trial Locations (1)

14642

University of Rochester Medical Center: Facility for Evaluation of Flu Vaccines, Rochester

All Listed Sponsors
collaborator

University of Rochester

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01674205 - Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines | Biotech Hunter | Biotech Hunter